- Home
- DRIO
DRIO
DarioHealth Corp.
as of 02-02-2026 2:16pm EST
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 84.1M | IPO Year: | N/A |
| Target Price: | $50.00 | AVG Volume (30 days): | 10.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.93 - $17.74 | Next Earning Date: | 03-09-2026 |
| Revenue: | $24,732,000 | Revenue Growth: | 7.29% |
| Revenue Growth (this year): | -9.74% | Revenue Growth (next year): | 7.64% |
Compare DRIO vs Leading Stocks
See how DRIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DRIO DarioHealth Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.